For emerging biotech companies, Europe is a highly attractive but incredibly complex market post-commercialisation. You’ve worked hard to bring your product to life, secured investment, and now you’re scaling rapidly. However, as you expand, it is essential that compliance remains a top priority alongside your commercial plans.
And that’s where many biotech companies stumble.
The European regulatory landscape is vast and nuanced, with regional legal and self-regulatory responsibilities and local market requirements that must be adhered to when commercialising in Europe – each layer of compliance adds complexity.
- The EFPIA Code sets the foundation for compliance in Europe—but it’s not enough on its own.
- Each country has its own implementation of the EFPIA framework, adding national-specific rules that must be followed.
- Without this dual understanding, Pharma teams risk planning strategies that cannot be executed locally—leading to wasted budgets, compliance risks, and launch delays.
The Challenge: Why Many Biotechs Struggle with European Compliance
- Your team is focused on growth, not regulatory pitfalls. Commercial teams are tasked with launching products, engaging HCPs, and building market share—not becoming compliance experts.
- Internal compliance teams are lean (or nonexistent). Unlike established Pharma companies, emerging brands don’t always have a fully built-out compliance department to guide them.
- Missteps can cost you market access, credibility, and investment confidence. Getting compliance wrong at launch isn’t just an operational headache—it can lead to financial and reputational damage.
- You don’t have time for trial and error. If you want to expand smoothly, compliance needs to be built into your foundation from day one.
How Pharma Integrity Academy Helps You Scale, Safely
At Pharma Integrity Academy, we remove the compliance burden so you can focus on growth.
We know what it’s like to build a business, enter new markets, and juggle competing priorities, which is why we created an operationally relevant, no-hassle compliance training solution designed specifically for scaling Pharma companies.
Comprehensive Compliance Training for Rapidly Expanding Teams
When you’re hiring fast, the last thing you need is disjointed, ad-hoc training that slows onboarding. We offer corporate rates and bulk-buy training packages, so every new hire—whether commercial, medical, or compliance, gets the same high-quality, standardised compliance training from day one.
- The EFPIA Code module provides a core foundation for companies entering Europe.
- The EFPIA Country Comparison module provides awareness of key variations in the UK, France, Germany, Italy, and Spain, helping regional and global teams understand compliance expectations.
- This is NOT a replacement for deep in-country training but gives the essential above-country awareness needed to plan effectively.
Ready-to-Go, Expert-Led Compliance Training
Many Pharma companies entering Europe don’t have time to build a training function from scratch. Our courses are developed by compliance experts who have worked in-house at leading Pharma companies, so you’re not just getting theory, you’re getting practical, real-world insights that are immediately applicable.
Training Designed for Non-Compliance Experts
Not everyone in a Pharma company is a compliance specialist. In fact, many teams operating in Europe for the first time have zero prior experience with local codes.
Our training breaks down the complex, fragmented EU regulatory environment into simple, actionable guidance that teams can actually use, without the confusion.
A Compliance Safety Net That Lets You Focus on Growth
Your focus is on commercial success, but without compliance, success is short-lived. We ensure that compliance is never a bottleneck by giving your teams the right knowledge at the right time.
- EFPIA compliance training ensures teams understand the core rules.
- Country comparison modules highlight key differences, so strategies align with local expectations.
- Teams get it right the first time, reducing approval delays and compliance risks.
The Results: A More Efficient, Risk-Free Approach to Expansion
- Faster Market Entry. Get your team trained before they hit the ground, avoiding costly delays.
- Lower Costs. Buying high-volume corporate training for the entire team is more efficient than expensive consultant fees, mistakes, or wasted internal resources.
- Clearer Compliance Understanding. No more confusion, no more guesswork—just practical, regulatory confidence.
- Risk Reduction. Compliance missteps can be costly. We help you stay ahead so you don’t pay the price later.
Are You Ready to Scale with Confidence?
Expanding into Europe shouldn’t mean navigating compliance alone.
Our Pharma Integrity Academy makes it easy, cost-effective, and scalable to train your teams, so you can grow your business without compliance slowing you down.
Get your team market-ready today. Explore our corporate training packages here: